Background In this meta-analysis, we aimed to evaluate the PAX8 immunohistochemical expressions in primary lung cancers and metastatic cancers to the lung.
Methods We identified and reviewed relevant articles from the PubMed databases. Ultimately, 18 articles were included in this meta-analysis. PAX8 expression rates were analyzed and compared between primary and metastatic lung cancers.
Results The PAX8 expression rate in primary lung cancers was 0.042 (95% confidence interval [CI], 0.025 to 0.071). PAX8 expression rates of small cell (0.129; 95% CI, 0.022 to 0.496) and non-small cell carcinomas of the lung (0.037; 95% CI, 0.022 to 0.061) were significantly different (p=.049 in a meta-regression test). However, the PAX8 expression rates of adenocarcinoma (0.013; 95% CI, 0.006 to 0.031) and squamous cell carcinoma (0.040; 95% CI, 0.016 to 0.097) were not significantly different. PAX8 expression rates of metastatic carcinomas to the lung varied, ranging from 1.8% to 94.9%. Metastatic carcinomas from the lung to other organs had a PAX8 expression rate of 6.3%. The PAX8 expression rates of metastatic carcinomas from the female genital organs, kidneys, and thyroid gland to the lung were higher than those of other metastatic carcinomas.
Conclusions Primary lung cancers had a low PAX8 expression rate regardless of tumor subtype. However, the PAX8 expression rates of metastatic carcinomas from the female genital organs, kidneys, and thyroid were significantly higher than those of primary lung cancers.
Citations
Citations to this article as recorded by
Prognostic value of PAX8 in small cell lung cancer Fengyun Tao, Hangyan Zhu, Jiayun Xu, Yanan Guo, Xin Wang, Lei Shao, Deng Pan, Guosheng Li, Rong Fang Heliyon.2024; 10(7): e28251. CrossRef
The combination of p16 and Rb expression pattern is helpful to predict high-risk HPV infection and the primary site in lymph node metastases of squamous cell carcinoma Ryosuke Kuga, Hidetaka Yamamoto, Fumiya Narutomi, Misa Suzuki, Rina Jiromaru, Takahiro Hongo, Kazuhisa Hachisuga, Nobuko Yasutake, Kiyoko Kato, Takashi Nakagawa, Yoshinao Oda Pathology - Research and Practice.2024; 263: 155642. CrossRef
Mesonephric adenocarcinoma of the uterine cervix with a prominent spindle cell component Yingying Fan, Ying He, Liang Sun, Tianmin Liu, Yangmei Shen Oncology Letters.2024;[Epub] CrossRef
Immunocytochemistry of effusions: Processing and commonly used immunomarkers Vinod B. Shidham, Beata Janikowski Cytojournal.2022; 19: 6. CrossRef
Significance analysis of PAX8 expression in endometrial carcinoma Shan Hu, Hua Gan, Fengmei Yang Medicine.2022; 101(42): e31159. CrossRef
Background Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis.
Methods The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted.
Results Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS.
Conclusions Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.
Citations
Citations to this article as recorded by
Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases Fangqian Du, Yuwei Xie, Shengze Wu, Mengling Ji, Bingzi Dong, Chengzhan Zhu Journal of Hepatocellular Carcinoma.2024; Volume 11: 1801. CrossRef
The Significance of Relative Claudin Expression in Odontogenic Tumors Ekarat Phattarataratip, Kraisorn Sappayatosok Head and Neck Pathology.2020; 14(2): 480. CrossRef
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer Simon Kind, Franziska Büscheck, Doris Höflmayer, Claudia Hube-Magg, Martina Kluth, Maria Christina Tsourlakis, Stefan Steurer, Till S. Clauditz, Andreas M. Luebke, Eike Burandt, Waldemar Wilczak, Andrea Hinsch, David Dum, Sören Weidemann, Christoph Fraune World Journal of Urology.2020; 38(9): 2185. CrossRef
Characterisation of endogenous Claudin‐1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock‐in cells Camille M.H. Clément, Maika S. Deffieu, Cristina M. Dorobantu, Thomas F. Baumert, Nilda Vanesa Ayala‐Nunez, Yves Mély, Philippe Ronde, Raphael Gaudin Biology of the Cell.2020; 112(5): 140. CrossRef
Comment on “Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis” Bolin Wang, Yan Huang Journal of Pathology and Translational Medicine.2019; 53(6): 411. CrossRef
Background The aim of this study is to elucidate the clinicopathological significances, including the prognostic role, of metastatic lymph node ratio (mLNR) and tumor deposit diameter in papillary thyroid carcinoma (PTC) through a retrospective review and meta-analysis.
Methods We categorized the cases into high (≥ 0.44) and low mLNR (< 0.44) and investigated the correlations with clinicopathological parameters in 64 PTCs with neck level VI lymph node (LN) metastasis. In addition, meta-analysis of seven eligible studies was used to investigate the correlation between mLNR and survival.
Results Among 64 PTCs with neck level VI LN metastasis, high mLNR was found in 34 PTCs (53.1%). High mLNR was significantly correlated with macrometastasis (tumor deposit diameter ≥ 0.2 cm), extracapsular spread, and number of metastatic LNs. Based on linear regression test, mLNR was significantly increased by the largest LN size but not the largest metastatic LN (mLN) size. High mLNR was not correlated with nuclear factor κB or cyclin D1 immunohistochemical expression, Ki-67 labeling index, or other pathological parameters of primary tumor. Based on meta-analysis, high mLNR significantly correlated with worse disease-free survival at the 5-year and 10-year follow-up (hazard ratio [HR], 4.866; 95% confidence interval [CI], 3.527 to 6.714 and HR, 5.769; 95% CI, 2.951 to 11.275, respectively).
Conclusions Our data showed that high mLNR significantly correlated with worse survival, macrometastasis, and extracapsular spread of mLNs. Further cumulative studies for more detailed criteria of mLNR are needed before application in daily practice.
Citations
Citations to this article as recorded by
Application and subgroup analysis of competing risks model based on different lymph node staging systems in differentiated thyroid cancer Zhe Xu Cao, Jiang Sheng Huang, Ming Ming Wang Updates in Surgery.2024; 76(5): 1927. CrossRef
Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer Helene Lindfors, Marie Karlsen, Ellinor Karlton, Jan Zedenius, Catharina Larsson, Catharina Ihre Lundgren, C. Christofer Juhlin, Ivan Shabo Scientific Reports.2023;[Epub] CrossRef
Incidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma Renan Aguera Pinheiro, Ana Kober Leite, Beatriz Godoi Cavalheiro, Evandro Sobroza de Mello, Luiz Paulo Kowalski, Leandro Luongo Matos Cancers.2023; 15(3): 943. CrossRef
A High-Quality Nomogram for Predicting Lung Metastasis in Newly Diagnosed Stage IV Thyroid Cancer: A Population-Based Study WenYi Wang, JiaJing Liu, XiaoFan Xu, LiQun Huo, XuLin Wang, Jun Gu Technology in Cancer Research & Treatment.2023;[Epub] CrossRef
Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield Il Ku Kang, Joonseon Park, Ja Seong Bae, Jeong Soo Kim, Kwangsoon Kim Cancers.2023; 15(11): 2947. CrossRef
Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer‐specific survival in medullary thyroid cancer Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle Head & Neck.2022; 44(12): 2717. CrossRef
Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas Yanfang Wang, Fang Nie, Guojuan Wang, Ting Liu, Tiantian Dong, Yamin Sun Cancer Management and Research.2021; Volume 13: 3403. CrossRef
Atypical Histiocytoid Cells and Multinucleated Giant Cells in Fine-Needle Aspiration Cytology of the Thyroid Predict Lymph Node Metastasis of Papillary Thyroid Carcinoma Ji Eun Choi, Ja Seong Bae, Dong-Jun Lim, So Lyung Jung, Chan Kwon Jung Cancers.2019; 11(6): 816. CrossRef
Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System Zeming Liu, Sichao Chen, Yihui Huang, Di Hu, Min Wang, Wei Wei, Chao Zhang, Wen Zeng, Liang Guo Frontiers in Oncology.2019;[Epub] CrossRef
Prognostic Implication of Metastatic Lymph Node Ratio in Colorectal Cancers: Comparison Depending on Tumor Location Jung-Soo Pyo, Young-Min Shin, Dong-Wook Kang Journal of Clinical Medicine.2019; 8(11): 1812. CrossRef
Fine-needle aspiration cytology (FNAC) is a screening test for triaging thyroid nodules, aiding in subsequent clinical management. However, the advantages have been overshadowed by the multiplicity of reporting systems and a wide range of nomenclature used. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was formulated in 2007, to give the world a uniform thyroid cytology reporting system, facilitating easy interpretation by the clinicians. Here, we review the status of thyroid FNAC in India in terms of various reporting systems used including a meta-analysis of the previously published data. An extensive literature search was performed using internet search engines. The reports with detailed classification system used in thyroid cytology were included. The meta-analysis of published data was compared with the implied risk of malignancy by TBSRTC. More than 50 studies were retrieved and evaluated. TBSRTC is currently the most widely used reporting system with different studies showing good efficacy and interobserver concordance. Ancillary techniques have, as of now, limited applicability and acceptability in thyroid cytology in India. Twenty-eight published articles met the criteria for inclusion in the meta-analysis. When compared with TBSRTC recommendations, the meta-analysis showed a higher risk of malignancy for categories I and III. Thyroid FNAC is practiced all over India. TBSRTC has found widespread acceptance, with most institutions using this system for routine thyroid cytology reporting. However, reasons for a high malignancy risk for categories I and III need to be looked into. Various possible contributing factors are discussed in the review.
Citations
Citations to this article as recorded by
Thermal imaging based pre-diagnostics tool for Graves’ disease Vaishali Sharma, Vandana K Dhingra, Snehlata Shakya, Ashok Kumar, Mayank Goswami Measurement Science and Technology.2024; 35(3): 035702. CrossRef
High Malignancy Risk and Its Predictors in South Indian Patients With Bethesda II Thyroid Nodules Sunanda Tirupati, Pradeep Puthenveetil, Shilpa Lakkundi, Anudeep Gaddam, Vijaya Sarathi Cureus.2024;[Epub] CrossRef
Nuclear features in thyroid cytology: features helpful for a morphological diagnosis in routine practice Priya Bhagwat, Sabine Pomplun Diagnostic Histopathology.2024; 30(6): 312. CrossRef
Evaluation of Thyroid Lesions by the Bethesda System for Reporting Thyroid Cytopathology Syed Asif Hashmi, Monika Aggrawal, Rahul Pandey, Deepika Gulati, Inam Danish Khan Journal of Marine Medical Society.2023; 25(1): 73. CrossRef
Incidence and Malignancy Rates in Thyroid Nodules in North-East Indian Population by Bethesda System: A Single Institutional Experience of 3 Years Suvamoy Chakraborty, Manu C. Balakrishnan, Vandana Raphael, Prachurya Tamuli, Anuradha Deka South Asian Journal of Cancer.2023; 12(02): 166. CrossRef
Evaluation of Concordance of Ultrasound, Cytology, and Histopathology in Solitary Thyroid Nodules Sunil Chumber, Surabhi Vyas, Kamal Kataria, Shipra Agarwal, Yashwant S Rathore, Gopal Puri, Sushma Yadav, Kanika Sharma, Amit Patidar Indian Journal of Endocrine Surgery and Research.2023; 18(1): 17. CrossRef
Cytomorphological Spectrum of Head and Neck Lesions by Fine Needle Aspiration Cytology in a Tertiary Care Center Amandeep Kaur, Sonali Poonia, Karandeep Singh, Dalbir Kaur, Mohit Madhukar, Ravish Godara Journal of Pharmacy and Bioallied Sciences.2023; 15(Suppl 1): S315. CrossRef
The Asian Thyroid Working Group, from 2017 to 2023 Kennichi Kakudo, Chan Kwon Jung, Zhiyan Liu, Mitsuyoshi Hirokawa, Andrey Bychkov, Huy Gia Vuong, Somboon Keelawat, Radhika Srinivasan, Jen-Fan Hang, Chiung-Ru Lai Journal of Pathology and Translational Medicine.2023; 57(6): 289. CrossRef
Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome Meenakshi Kamboj, Anurag Mehta, Sunil Pasricha, Gurudutt Gupta, Anila Sharma, Garima Durga Journal of Cytology.2022; 39(1): 44. CrossRef
Is Surgery Necessary in Benign Thyroid Lesions? Pushkar Chaudhary, Naseem Noorunnisa Journal of Datta Meghe Institute of Medical Sciences University.2022; 17(3): 799. CrossRef
Effect of the Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision on Indian Thyroid Fine-Needle Aspiration Practice Chanchal Rana, Pooja Ramakant, Divya Goel, Akanksha Singh, KulRanjan Singh, Suresh Babu, Anand Mishra American Journal of Clinical Pathology.2021; 156(2): 320. CrossRef
The combination of ACR‐Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules—An institutional experience Shanmugasundaram Sakthisankari, Sreenivasan Vidhyalakshmi, Sivanandam Shanthakumari, Balalakshmoji Devanand, Udayasankar Nagul Cytopathology.2021; 32(4): 472. CrossRef
Differentiated Thyroid Cancer Anita M. Borges Journal of Head & Neck Physicians and Surgeons.2021; 9(2): 69. CrossRef
Risk of malignancy in Thyroid “Atypia of undetermined significance/Follicular lesion of undetermined significance” and its subcategories – A 5-year experience Abha Thakur, Haimanti Sarin, Dilpreet Kaur, Deepak Sarin Indian Journal of Pathology and Microbiology.2019; 62(4): 544. CrossRef
Thyroid FNA cytology in Asian practice—Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas K. Kakudo, M. Higuchi, M. Hirokawa, S. Satoh, C. K. Jung, A. Bychkov Cytopathology.2017; 28(6): 455. CrossRef
The Use of Fine-Needle Aspiration (FNA) Cytology in Patients with Thyroid Nodules in Asia: A Brief Overview of Studies from the Working Group of Asian Thyroid FNA Cytology Chan Kwon Jung, SoonWon Hong, Andrey Bychkov, Kennichi Kakudo Journal of Pathology and Translational Medicine.2017; 51(6): 571. CrossRef
Background Human papillomavirus (HPV) is a well-established oncogenic virus of cervical, anogenital, and oropharyngeal cancer. Various subtypes of HPV have been detected in 0% to 60% of breast cancers. The roles of HPV in the carcinogenesis of breast cancer remain controversial. This study was performed to determine the prevalence of HPV-positive breast cancer in Korean patients and to evaluate the possibility of carcinogenic effect of HPV on breast.
Methods Meta-analysis was performed in 22 case-control studies for HPV infection in breast cancer. A total of 123 breast cancers, nine intraductal papillomas and 13 nipple tissues of patients with proven cervical HPV infection were tested by real-time polymerase chain reaction to detect 28 subtypes of HPV. Breast cancers were composed of 106 formalin-fixed and paraffin embedded (FFPE) breast cancer samples and 17 touch imprint cytology samples of breast cancers.
Results The overall odds ratio between breast cancer and HPV infection was 5.43 (95% confidence interval, 3.24 to 9.12) with I2 = 34.5% in meta-analysis of published studies with case-control setting and it was statistically significant. HPV was detected in 22 cases of breast cancers (17.9%) and two cases of intaductal papillomas (22.2%). However, these cases had weak positivity.
Conclusions These results failed to serve as significant evidence to support the relationship between HPV and breast cancer. Further study with larger epidemiologic population is merited to determine the relationship between HPV and breast cancer.
Citations
Citations to this article as recorded by
Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence Ikuko Kato, Jilei Zhang, Jun Sun Cancers.2022; 14(2): 425. CrossRef
Breast cancer association with oncogenic papillomaviruses: papillomaviral DNA detection in breast cancer cells G. M. Volgareva Advances in Molecular Oncology.2022; 9(2): 10. CrossRef
Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease Erika Maldonado-Rodríguez, Marisa Hernández-Barrales, Adrián Reyes-López, Susana Godina-González, Perla I. Gallegos-Flores, Edgar L. Esparza-Ibarra, Irma E. González-Curiel, Jesús Aguayo-Rojas, Adrián López-Saucedo, Gretel Mendoza-Almanza, Jorge L. Ayala- Current Issues in Molecular Biology.2022; 44(8): 3648. CrossRef
Risk Role of Breast Cancer in Association with Human Papilloma Virus among Female Population in Taiwan: A Nationwide Population-Based Cohort Study Chia-Hsin Liu, Chi-You Liao, Ming-Hsin Yeh, James Cheng-Chung Wei Healthcare.2022; 10(11): 2235. CrossRef
HPV-Associated Breast Cancer: Myth or Fact? Erik Kudela, Eva Kudelova, Erik Kozubík, Tomas Rokos, Terezia Pribulova, Veronika Holubekova, Kamil Biringer Pathogens.2022; 11(12): 1510. CrossRef
Assessment of Human Papillomavirus Infection and Risk Factors in Egyptian Women With Breast Cancer Nabila El-Sheikh, Nahla O Mousa, Amany M Tawfeik, Alaa M Saleh, Iman Elshikh, Mohamed Deyab, Faten Ragheb, Manar M Moneer, Ahmed Kawashti, Ahmed Osman, Mohamed Elrefaei Breast Cancer: Basic and Clinical Research.2021;[Epub] CrossRef
Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma Hua Guo, Juan P. Idrovo, Jin Cao, Sudarshana Roychoudhury, Pooja Navale, Louis J. Auguste, Tawfiqul Bhuiya, Silvat Sheikh-Fayyaz Clinical Breast Cancer.2021; 21(6): e638. CrossRef
Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent? Rancés Blanco, Diego Carrillo-Beltrán, Juan P. Muñoz, Alejandro H. Corvalán, Gloria M. Calaf, Francisco Aguayo Biology.2021; 10(8): 804. CrossRef
Systematic review and meta-analysis of the papillomavirus prevalence in breast cancer fresh tissues Geilson Gomes de Oliveira, Ana Katherine Gonçalves, José Eleutério, Luiz Gonzaga Porto Pinheiro Breast Disease.2021; 41(1): 123. CrossRef
Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge? Fatih Levent Balci, Cihan Uras, Sheldon Marc Feldman Cancer Treatment and Research Communications.2019; 19: 100122. CrossRef
Is the HPV virus responsible for the development of breast cancer? Erik Kudela, Marcela Nachajova, Jan Danko The Breast Journal.2019; 25(5): 1053. CrossRef
Absence of Human Papillomavirus in Benign and Malignant Breast Tissue Maryam Kazemi Aghdam, Seyed Alireza Nadji, Azadeh Alvandimanesh, Maliheh Khoddami, Yassaman Khademi Iranian Journal of Pathology.2019; 14(4): 279. CrossRef
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV) James S. Lawson, Brian Salmons, Wendy K. Glenn Frontiers in Oncology.2018;[Epub] CrossRef
Viral infections and breast cancer – A current perspective O.M. Gannon, A. Antonsson, I.C. Bennett, N.A. Saunders Cancer Letters.2018; 420: 182. CrossRef
Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer Wasifa Naushad, Orooj Surriya, Hajra Sadia Infection, Genetics and Evolution.2017; 54: 230. CrossRef
Background The clinicopathological characteristics and conclusive treatment modality for multifocal papillary thyroid microcarcinoma (mPTMC) have not been fully established.
Methods A retrospective study, systematic review, and meta-analysis were conducted to elucidate the clinicopathological significance of mPTMC. We investigated the multiplicity of 383 classical papillary thyroid microcarcinomas (PTMCs) and the clinicopathological significance of incidental mPTMCs. Correlation between tumor recurrence and multifocality in PTMCs was evaluated through a systematic review and meta-analysis.
Results Tumor multifocality was identified in 103 of 383 PTMCs (26.9%). On linear regression analysis, primary tumor diameter was significantly correlated with tumor number (R2=0.014, p=.021) and supplemental tumor diameter (R2=0.117, p=.023). Of 103 mPTMCs, 61 (59.2%) were non-incidental, with tumor detected on preoperative ultrasonography, and 42 (40.8%) were diagnosed (incidental mPTMCs) on pathological examination. Lymph node metastasis and higher tumor stage were significantly correlated with tumor multifocality. However, there was no difference in nodal metastasis or tumor stage between incidental and non-incidental mPTMCs. On meta-analysis, tumor multifocality was significantly correlated with tumor recurrence in PTMCs (odds ratio, 2.002; 95% confidence interval, 1.475 to 2.719, p<.001).
Conclusions Our results show that tumor multifocality in PTMC, regardless of manner of detection, is significantly correlated with aggressive tumor behavior.
Citations
Citations to this article as recorded by
Retrospective comparison of individual risk factors hemithyroidectomy and thyroidectomy in patients with papillary carcinoma of the thyroid gland in combination with autoimmune thyroiditis E. V. Ryabchenko Head and Neck Tumors (HNT).2023; 12(4): 71. CrossRef
Individual risk factors for recurrence after hemithyroidectomy and thyroidectomy in patients with papillary thyroid microcarcinoma in the presence of autoimmune thyroiditis E.V. Ryabchenko Onkologiya. Zhurnal imeni P.A.Gertsena.2023; 12(3): 20. CrossRef
The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis Zhu-juan Wu, Bao-ying Xia, Zi-wei Chen, Hao Gong, Munire Abuduwaili, Zhi-chao Xing, An-ping Su Frontiers in Endocrinology.2023;[Epub] CrossRef
Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma Mine Araz, Elgin Özkan, Pınar Gunduz, Cigdem Soydal, N. Özlem Küçük, K. Metin Kır Cancer Biotherapy and Radiopharmaceuticals.2022; 37(1): 56. CrossRef
Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis Ke-cheng Jiang, Bei Lin, Yu Zhang, Ling-qian Zhao, Ding-cun Luo Frontiers in Endocrinology.2022;[Epub] CrossRef
The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma Changlin Li, Haixia Guan, Qiao He, Yishen Zhao, Nan liang, Jiao Zhang, Gianlorenzo Dionigi, Hui Sun Endocrine.2021; 74(3): 646. CrossRef
Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance Ryuta Nagaoka, Aya Ebina, Kazuhisa Toda, Tomoo Jikuzono, Marie Saitou, Masaomi Sen, Hiroko Kazusaka, Mami Matsui, Keiko Yamada, Hiroki Mitani, Iwao Sugitani World Journal of Surgery.2021; 45(9): 2769. CrossRef
Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules Patrick D. Chin, Catherine Y. Zhu, Dipti P. Sajed, Gregory A. Fishbein, Michael W. Yeh, Angela M. Leung, Masha J. Livhits Endocrine Pathology.2020; 31(4): 377. CrossRef
Application of Ultrasonography in the Diagnosis and Management of Papillary Thyroid Microcarcinoma Huang, MD Kun, Liu, MD Ji-Bin ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY.2020; 4(4): 284. CrossRef
Analysis of Malignant Thyroid Neoplasms with a Striking Rise of Papillary Microcarcinoma in an Endemic Goiter Region Alka Mary Mathai, K. Preetha, S. Valsala Devi, Sam Vicliph, Raja Pradeep, Aqib Shaick Indian Journal of Otolaryngology and Head & Neck Surgery.2019; 71(S1): 121. CrossRef
The first postoperative-stimulated serum thyroglobulin is a prognostic factor for thyroid microcarcinomas Isabela de Oliveira Amui, José Vicente Tagliarini, Emanuel C. Castilho, Mariângela de Alencar Marques, Yoshio Kiy, José Eduardo Corrente, Gláucia M.F.S. Mazeto Brazilian Journal of Otorhinolaryngology.2019; 85(1): 37. CrossRef
Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases Claudio Spinelli, Leonardo Rallo, Riccardo Morganti, Valentina Mazzotti, Alessandro Inserra, Giovanni Cecchetto, Maura Massimino, Paola Collini, Silvia Strambi Journal of Pediatric Surgery.2019; 54(3): 521. CrossRef
The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study Claudio Gambardella, Renato Patrone, Francesco Di Capua, Chiara Offi, Claudio Mauriello, Guglielmo Clarizia, Claudia Andretta, Andrea Polistena, Alessandro Sanguinetti, Pietrogiorgio Calò, Giovanni Docimo, Nicola Avenia, Giovanni Conzo BMC Surgery.2019;[Epub] CrossRef
Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors C. Spinelli, F. Tognetti, S. Strambi, R. Morganti, M. Massimino, P. Collini World Journal of Surgery.2018; 42(8): 2444. CrossRef
Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects Shuai Xue, Peisong Wang, Zachary A. Hurst, Yi Seok Chang, Guang Chen Frontiers in Endocrinology.2018;[Epub] CrossRef
A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Tae Yong Kim, Young Kee Shong, Won Bae Kim European Journal of Endocrinology.2017; 176(4): 371. CrossRef
Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience Shuai Xue, Peisong Wang, Jia Liu, Guang Chen World Journal of Surgical Oncology.2017;[Epub] CrossRef
Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Tae Yong Kim, Minkyu Han, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim Annals of Surgical Oncology.2017; 24(9): 2596. CrossRef
Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients Shuai Xue, Peisong Wang, Jia Liu, Guang Chen World Journal of Surgery.2017; 41(12): 3139. CrossRef
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer Fei Wang, Xiaolong Yu, Xiaopei Shen, Guangwu Zhu, Yueye Huang, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka, Alfred K Lam, Caterina Mian, Federica Vianello, Linwah Yip, Gar The Journal of Clinical Endocrinology & Metabolism.2017; 102(9): 3241. CrossRef
Evaluation of surgical results of micropapillary thyroid cancers according to tumor size and focality Bekir Uçan, Muhammed Erkam Sencar, Muhammed Kızılgül, Mustafa Özbek, İlknur Öztürk Ünsal, Erman Çakal Ortadoğu Tıp Dergisi.2017; 9(3): 123. CrossRef
Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients Kai Qian, Kai Guo, Xiaoke Zheng, Tuanqi Sun, Duanshu Li, Yi Wu, Qinghai Ji, Zhuoying Wang Oncotarget.2017; 8(39): 65836. CrossRef
Background While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinico-pathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC). Methods: The present study investigated the correlation between MUC2 expression and clinico-pathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs. Results: MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p=.001, p=.001, and p=.011, respectively). However, MUC2 expression was not correlated with Lauren’s classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren’s classification, pN stage, or pTNM stage. Conclusions: MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.
Citations
Citations to this article as recorded by
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases Karina Malmros, Andreas Lindholm, Halla Vidarsdottir, Karin Jirström, Björn Nodin, Johan Botling, Johanna S. M. Mattsson, Patrick Micke, Maria Planck, Mats Jönsson, Johan Staaf, Hans Brunnström Virchows Archiv.2024; 485(2): 347. CrossRef
Gastric epithelial histology and precancerous conditions Hang Yang, Wen-Juan Yang, Bing Hu World Journal of Gastrointestinal Oncology.2022; 14(2): 396. CrossRef
COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells Shen Jiangang, Kang Nayoung, Wang Hongfang, Li Junda, Chen Li, Bai Xuefeng, Li Mingsong BMC Molecular and Cell Biology.2022;[Epub] CrossRef
Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study Pascale Tomasini, Fabrice Barlesi, Sophie Gilles, Isabelle Nanni-Metellus, Riccardo Soffietti, Emilie Denicolai, Eric Pellegrino, Emilie Bialecki, L’Houcine Ouafik, Philippe Metellus Oncotarget.2020; 11(50): 4648. CrossRef
A High Ki67/BCL2 Index Could Predict Lower Disease-Free and Overall Survival in Intestinal-Type Gastric Cancer Kyueng-Whan Min, Dong-Hoon Kim, Byoung Kwan Son, Dong Hyun Kim, Eun-Kyung Kim, Jinwon Seo, Sang Bong Ahn, Yun Ju Jo, Young Sook Park, Junghoon Ha European Surgical Research.2017; 58(3-4): 158. CrossRef